GO:0023057 negative regulation of signaling: Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0023057 (negative regulation of signaling) describes any biological process that stops, prevents, or reduces the frequency, rate, or extent of a signaling process.
• Negative regulation of signaling is essential for preventing excessive or inappropriate pathway activation, thereby maintaining cellular homeostasis and preventing disease.
• Key mechanisms include decoy receptors, inhibitory adaptor proteins, phosphatases, ubiquitin ligases, and feedback phosphorylation of signaling intermediates.
• Dysregulation of negative regulators contributes to cancer, autoimmune diseases, chronic inflammation, and developmental disorders.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of negative regulators in signaling pathways.
• Studying negative regulation of signaling requires integrated approaches such as phosphoproteomics, RNA-seq, and functional rescue experiments.
Description
Negative regulation of signaling (GO:0023057) encompasses any process that stops, prevents, or reduces the frequency, rate, or extent of a signaling process. Signaling pathways are tightly controlled by both positive and negative modulators to ensure appropriate cellular responses to external and internal cues. Without negative regulation, signaling can become hyperactive, leading to pathological conditions such as cancer, autoimmunity, and chronic inflammation. This article provides a comprehensive overview of the mechanisms, key genes, and research methods used to study negative regulation of signaling, with a focus on publication-ready insights for researchers.
negative regulation of signaling At A Glance
| GO ID | GO:0023057 |
|---|---|
| GO term | negative regulation of signaling |
| Ontology | biological_process |
| Synonym | negative regulation of signaling process, negative regulation of signalling process |
| Major function | Attenuation or termination of signal transduction pathways to maintain cellular homeostasis |
| Key mechanisms | Inhibitory receptors, phosphatases, ubiquitin ligases, decoy receptors, feedback phosphorylation |
| Disease relevance | Cancer, autoimmune diseases, chronic inflammation, developmental disorders |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, phosphoproteomics, RNA-seq |
What Is GO:0023057?
According to the Gene Ontology, negative regulation of signaling (GO:0023057) is defined as any process that stops, prevents, or reduces the frequency, rate or extent of a signaling process. This term is a biological process and includes synonyms such as negative regulation of signaling process and negative regulation of signalling process. It covers diverse molecular mechanisms, including the action of inhibitory receptors, phosphatases, ubiquitin ligases, and decoy molecules that attenuate signal transduction cascades.
Why Is negative regulation of signaling Important in Cell Biology?
Negative regulation of signaling is critical for preventing excessive or inappropriate activation of cellular pathways. It ensures that signals are transient and context-specific, thereby protecting cells from uncontrolled proliferation, inflammation, and apoptosis. Dysregulation of negative regulators is implicated in a wide range of human diseases, making them attractive targets for therapeutic intervention and drug discovery.
• Prevents hyperactivation of immune signaling pathways, reducing risk of autoimmune diseases.
• Controls cell growth and proliferation, and its loss contributes to oncogenesis.
• Maintains tissue homeostasis by terminating developmental signals.
• Modulates inflammatory responses in macrophages and other immune cells.
• Regulates antiviral signaling to avoid excessive interferon production.
• Provides feedback control in cytokine signaling pathways.
• Influences synaptic signaling and neuronal function.
• Is essential for proper plant development and stress responses.
• Offers therapeutic targets for cancer and inflammatory diseases.
• Enables precise experimental dissection using CRISPR-based models.
What Happens During negative regulation of signaling?
Initiation of negative feedback
In simple terms: After a signal turns on a pathway, the cell quickly starts a process to turn it off.
Negative regulation often begins with the activation of feedback loops. For example, in cytokine signaling, the induction of SOCS proteins provides a classic negative feedback mechanism that attenuates the JAK-STAT pathway. Similarly, in RIG-I-like receptor signaling, negative regulators are upregulated following viral detection to prevent excessive interferon responses.
Recruitment of inhibitory molecules
In simple terms: Specific proteins are brought in to block or dampen the signal.
Inhibitory molecules such as phosphatases (e.g., SHP-1, PTEN), ubiquitin ligases (e.g., Cbl, SOCS), and inhibitory adaptors are recruited to activated receptor complexes. These molecules can dephosphorylate key signaling intermediates or target them for degradation. For instance, the adaptor protein SEM-5 negatively regulates LET-23 signaling in C. elegans.
Signal attenuation and termination
In simple terms: The signal is reduced or completely stopped.
Once inhibitory molecules are in place, they reduce the frequency, rate, or extent of signaling. This can occur through dephosphorylation of receptor tyrosine kinases, degradation of signaling proteins, or sequestration of signaling components. In TGF-beta signaling, inhibitory Smads (I-Smads) block receptor-mediated phosphorylation of R-Smads, thereby terminating the signal.
Resolution and resetting
In simple terms: The cell returns to its resting state and prepares for future signals.
After negative regulation, the signaling components are either degraded or recycled, allowing the cell to respond to new stimuli. This resetting is crucial for maintaining responsiveness and preventing desensitization. In plant phytochrome signaling, negative regulators such as COP1 and PIFs are degraded or inactivated to reset the system.
Key Genes Involved in GO:0023057 negative regulation of signaling
The following genes and proteins are key players in negative regulation of signaling, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SOCS1 | Negative regulator of cytokine signaling via JAK-STAT inhibition | Autoimmunity, inflammation, cancer |
| SOCS3 | Inhibits JAK-STAT and other cytokine pathways | Inflammation, metabolic disorders |
| PTEN | Lipid phosphatase that negatively regulates PI3K-AKT signaling | Cancer, tumor suppressor |
| SHP-1 (PTPN6) | Protein tyrosine phosphatase that attenuates receptor signaling | Immune regulation, leukemia |
| Cbl | E3 ubiquitin ligase that targets RTKs for degradation | Cancer, signaling attenuation |
| I-Smads (SMAD6/7) | Inhibit TGF-beta/BMP signaling | Fibrosis, cancer |
| RIG-I (DDX58) | Sensor of viral RNA; its signaling is negatively regulated | Antiviral immunity |
| MDA5 (IFIH1) | Cytosolic RNA sensor; negatively regulated to prevent autoimmunity | Autoimmune diseases |
| MAVS | Adaptor in RLR signaling; targeted by negative regulators | Antiviral signaling |
| SEM-5 | Adaptor protein that negatively regulates LET-23 RTK signaling | Developmental signaling |
| COP1 | E3 ubiquitin ligase that negatively regulates phytochrome signaling | Plant development |
| PIFs | Transcription factors that negatively regulate phytochrome responses | Plant light signaling |
| SPRY proteins | Inhibit FGF signaling by blocking receptor activation | Development, cancer |
| DUSP1 | Dual-specificity phosphatase that inactivates MAPKs | Inflammation, cancer |
| A20 (TNFAIP3) | Ubiquitin-editing enzyme that inhibits NF-kB signaling | Autoimmunity, lymphoma |
| IRAK-M | Inhibitory kinase that negatively regulates TLR signaling | Innate immunity |
| TRAF3 | Adaptor that negatively regulates NF-kB and MAPK pathways | Antiviral immunity |
| USP18 | Deubiquitinase that negatively regulates interferon signaling | Antiviral responses |
How Is negative regulation of signaling Regulated?
Negative regulation of signaling is itself tightly regulated at multiple levels. Transcriptionally, many negative regulators are induced by the very pathways they inhibit, forming negative feedback loops. Post-translationally, their activity can be modulated by phosphorylation, ubiquitination, and subcellular localization. For example, SOCS proteins are rapidly induced by cytokines and then degraded via the ubiquitin-proteasome system, ensuring transient inhibition. In RLR signaling, negative regulators such as USP18 and TRAF3 are regulated by interferon and viral proteins. Additionally, microRNAs and long non-coding RNAs can fine-tune the expression of negative regulators.
negative regulation of signaling and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTEN | Cancer (e.g., glioblastoma, prostate cancer) | PTEN knockout cell lines, mouse models |
| SOCS1 | Autoimmune diseases, lymphoma | SOCS1 knockout mice, CRISPR KO in immune cells |
| A20 (TNFAIP3) | Autoimmunity, B-cell lymphoma | A20 knockout mice, point mutation knock-in |
| SPRY2 | Craniosynostosis, skeletal dysplasia | Spry2 knockout mice, overexpression in chondrocytes |
| USP18 | Interferonopathies, viral susceptibility | USP18 knockout cells, knock-in of patient mutations |
Cancer
Loss of negative regulators of signaling often leads to uncontrolled cell proliferation and survival. PTEN, a negative regulator of PI3K-AKT signaling, is one of the most frequently mutated tumor suppressors in human cancers. Similarly, SOCS1 and SOCS3 are silenced in various malignancies, contributing to constitutive JAK-STAT activation. Targeting these negative regulators or their pathways is a promising therapeutic strategy.
Autoimmune and inflammatory diseases
Defective negative regulation of immune signaling results in chronic inflammation and autoimmunity. For instance, polymorphisms in SOCS1 and A20 are associated with autoimmune conditions. Negative regulators of RLR signaling, such as USP18, prevent excessive interferon production; their dysfunction can lead to interferonopathies.
Developmental disorders
Negative regulation of signaling is essential for proper embryonic development. Mutations in SPRY proteins, which inhibit FGF signaling, cause skeletal dysplasias and craniosynostosis. In plants, disruption of COP1-mediated negative regulation of phytochrome signaling leads to abnormal photomorphogenesis.
From negative regulation of signaling-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate pathway Y? | CRISPR knockout (KO) cell line |
| Does a specific phosphorylation site in gene X control its inhibitory function? | Point mutation knock-in |
| Does a disease-associated mutation in gene X impair negative regulation? | Knock-in of mutant allele |
| Where and when is gene X expressed during signaling? | Tagged knock-in (e.g., GFP, HA) |
| Does overexpression of gene X suppress pathway Y? | Overexpression cell line |
| Which downstream targets are affected by loss of gene X? | RNA-seq and phosphoproteomics in KO cells |
How to Study the negative regulation of signaling Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function phenotype | Identify negative regulators of a pathway |
| Phosphoproteomics | Global phosphorylation changes | Map signaling nodes affected by negative regulators |
| RNA-seq | Transcriptional changes | Discover downstream targets and feedback genes |
| Western blot | Protein expression and phosphorylation | Validate specific signaling changes |
| Co-immunoprecipitation | Protein-protein interactions | Identify inhibitory complexes |
| Luciferase reporter assays | Pathway activity | Measure signaling output in real time |
| Flow cytometry | Cell surface markers, viability | Assess immune cell activation |
| CRISPR activation (CRISPRa) | Gain-of-function | Overexpress negative regulators to suppress signaling |
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify negative regulators of specific signaling pathways. For example, a screen for regulators of RLR signaling identified multiple negative regulators. These screens are powerful for discovering novel components.
Phosphoproteomics
Mass spectrometry-based phosphoproteomics allows global mapping of phosphorylation changes upon loss or gain of negative regulators. This is particularly useful for pathways regulated by phosphatases and kinases.
RNA sequencing (RNA-seq)
RNA-seq measures transcriptional changes following perturbation of negative regulators, revealing downstream target genes and feedback loops.
Functional rescue experiments
Re-expression of wild-type or mutant negative regulators in knockout cells can confirm causality and dissect domain functions.
How CRISPR Can Be Used to Study GO:0023057 negative regulation of signaling
Knockout
CRISPR knockout of a putative negative regulator can reveal its role in signaling. For example, knocking out SOCS1 in immune cells leads to hyperactivation of JAK-STAT signaling. Similarly, PTEN knockout increases PI3K-AKT signaling.
Point Mutation
Introducing point mutations in catalytic domains or phosphorylation sites of negative regulators can dissect their mechanism. For instance, mutation of the phosphatase domain of SHP-1 abolishes its inhibitory function.
Knock-in
Knock-in of disease-associated mutations or tagged versions of negative regulators allows study of their function in a physiological context. For example, knock-in of a USP18 mutation linked to interferonopathy can model the disease.
Overexpression
Overexpression of negative regulators can suppress signaling pathways and is useful for validating their inhibitory capacity. For example, overexpression of SPRY proteins blocks FGF signaling.
How EDITGENE Supports negative regulation of signaling Research
Researchers studying negative regulation of signaling-related genes often need to determine whether a candidate gene is causally involved in attenuating a pathway, and to dissect the precise molecular mechanism. This requires precise genetic models that can knockout, mutate, knock-in, or overexpress the gene of interest in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of signaling research.
Frequently Asked Questions About negative regulation of signaling
What is negative regulation of signaling (GO:0023057)?
It is any biological process that stops, prevents, or reduces the frequency, rate, or extent of a signaling process, as defined by the Gene Ontology.
What genes are involved in negative regulation of signaling?
Key genes include SOCS1, SOCS3, PTEN, SHP-1, Cbl, I-Smads, A20, and many others that act as inhibitory molecules in various pathways.
How does negative regulation of signaling prevent disease?
By attenuating excessive or inappropriate pathway activation, it prevents conditions such as cancer, autoimmunity, and chronic inflammation.
What are the mechanisms of negative regulation of signaling?
Mechanisms include feedback inhibition, recruitment of phosphatases and ubiquitin ligases, decoy receptors, and degradation of signaling components.
Which diseases are linked to defects in negative regulation of signaling?
Cancer, autoimmune diseases, inflammatory disorders, and developmental abnormalities are associated with impaired negative regulation.
How can CRISPR be used to study negative regulation of signaling?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of negative regulator genes to study their function.
What methods are used to study negative regulation of signaling?
Common methods include CRISPR screens, phosphoproteomics, RNA-seq, Western blot, and co-immunoprecipitation.
What is the role of SOCS proteins in negative regulation of signaling?
SOCS proteins are induced by cytokines and inhibit JAK-STAT signaling through negative feedback, preventing excessive immune responses.
How does PTEN negatively regulate signaling?
PTEN is a lipid phosphatase that dephosphorylates PIP3 to PIP2, thereby antagonizing PI3K-AKT signaling and suppressing tumor growth.
Why is negative regulation of signaling important in plants?
In plants, negative regulation of phytochrome signaling controls light responses and developmental transitions, as shown by COP1 and PIF proteins.
Conclusion
Negative regulation of signaling (GO:0023057) is a fundamental biological process that ensures appropriate intensity and duration of cellular signals. Its dysregulation underlies numerous human diseases, making it a rich area for therapeutic targeting. Advances in CRISPR-based models and high-throughput technologies continue to uncover new negative regulators and mechanisms, offering promising avenues for drug discovery and precision medicine.
References
- 1. Chang MX. 2021. The negative regulation of retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) signaling pathway in fish.. Dev Comp Immunol 119:104038 PMID: 33548290
- 2. Yasukawa H et al.. 2000. Negative regulation of cytokine signaling pathways.. Annu Rev Immunol 18:143-64 PMID: 10837055
- 3. Cheng MC et al.. 2021. Phytochrome Signaling Networks.. Annu Rev Plant Biol 72:217-244 PMID: 33756095
- 4. Miyazono K. 2000. Positive and negative regulation of TGF-beta signaling.. J Cell Sci 113 ( Pt 7):1101-9 PMID: 10704361
- 5. Korsensky L et al.. 2016. Regulation of FGF signaling: Recent insights from studying positive and negative modulators.. Semin Cell Dev Biol 53:101-14 PMID: 26903404
- 6. Baig MS et al.. 2024. Adaptor molecules mediate negative regulation of macrophage inflammatory pathways: a closer look.. Front Immunol 15:1355012 PMID: 38482001
- 7. Worby C et al.. 2000. Positive versus negative signaling of LET-23: regulation through the adaptor protein, SEM-5.. Sci STKE 2000(63):pe2 PMID: 11752629
- 8. Quicke KM et al.. 2017. Negative regulators of the RIG-I-like receptor signaling pathway.. Eur J Immunol 47(4):615-628 PMID: 28295214
